FAM119B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.524200E-01
Normal-vs-Stage2
6.744400E-01
Normal-vs-Stage3
6.534600E-01
Normal-vs-Stage4
5.886200E-01
Stage1-vs-Stage2
5.122200E-01
Stage1-vs-Stage3
1.554160E-02
Stage1-vs-Stage4
6.927600E-01
Stage2-vs-Stage3
2.818200E-01
Stage2-vs-Stage4
7.796000E-01
Stage3-vs-Stage4
9.661600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.862200E-01
Normal-vs-AfricanAmerican
6.457200E-01
Normal-vs-Asian
8.636600E-01
Caucasian-vs-AfricanAmerican
2.229400E-01
Caucasian-vs-Asian
2.551200E-01
AfricanAmerican-vs-Asian
7.491200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.110400E-01
Normal-vs-Female
6.472600E-01
Male-vs-Female
3.623200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.032600E-01
Normal-vs-Age(41-60Yrs)
4.383600E-01
Normal-vs-Age(61-80Yrs)
9.282800E-01
Normal-vs-Age(81-100Yrs)
9.811600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.125200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.847600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.470400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.397400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.476210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.120200E-01
Normal-vs-Daily Drinker
9.303600E-01
Normal-vs-Weekly Drinker
6.516400E-01
Normal-vs-Occasional Drinker
6.898000E-01
Normal-vs-Social Drinker
3.998400E-01
Non Drinker-vs-Daily Drinker
2.430400E-01
Non Drinker-vs-Weekly Drinker
9.296000E-01
Non Drinker-vs-Occasional Drinker
9.230000E-01
Non Drinker-vs-Social Drinker
5.943800E-01
Daily Drinker-vs-Weekly Drinker
2.213800E-01
Daily Drinker-vs-Occasional Drinker
2.889600E-01
Daily Drinker-vs-Social Drinker
4.100000E-02
Weekly Drinker-vs-Occasional Drinker
9.959800E-01
Weekly Drinker-vs-Social Drinker
6.554400E-01
Occasional Drinker-vs-Social Drinker
6.854600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.254000E-01
Normal-vs-Grade 2
3.093600E-01
Normal-vs-Grade 3
2.603400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.638600E-01
Grade 1-vs-Grade 3
1.067620E-02
Grade 1-vs-Grade 4
7.254000E-01
Grade 2-vs-Grade 3
4.261800E-02
Grade 2-vs-Grade 4
3.093600E-01
Grade 3-vs-Grade 4
2.603400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.239400E-01
Normal-vs-NonDiabetic
7.358200E-01
Diabetic-vs-NonDiabetic
9.959200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.415800E-01
Normal-vs-NoPancreatitis
7.630000E-01
Pancreatitis-vs-NoPancreatitis
6.057200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.030600E-01
Normal-vs-N1
5.996000E-01
N0-vs-N1
2.446100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.403200E-01
Normal-vs-TP53-NonMutant
9.815200E-01
TP53-Mutant-vs-TP53-NonMutant
2.418600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
